Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 80.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.25%)
Open: 82.50
High: 82.50
Low: 82.50
Prev. Close: 82.50
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Bleepa®

17 Oct 2019 07:00

RNS Number : 1508Q
Feedback PLC
17 October 2019
 

Feedback plc

 

Update re Bleepa® 

 

Cambridge, 17 October 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, is pleased to provide an update on Bleepa®.

 

The Company is considering a number of potential opportunities for Bleepa® following its launch at the NHS Expo in September 2019. The Company is in advanced discussions with NHS pilot sites whilst additionally pursuing a number of commercial opportunities within and outside the NHS, and hopes to commence Bleepa® pilot schemes in the near future.

 

To date, the Bleepa® product has been well received by the healthcare community and the Company believes that it will enable a number of healthcare providers to provide faster, safer, more efficient care. The Company looks forward to providing further updates in due course.

 

Tom Oakley, CEO of Feedback plc, said:

 

"We are very encouraged by the response to Bleepa® having discussed this with senior NHS executives and clinicians at NHS Expo. The feedback that we have received is that Bleepa® clearly has applications across the healthcare sector, not only in individual hospital settings but also in community and cross site clinical settings. We look forward to making further announcements in relation to Bleepa®, in due course."

 

The Company continues to progress with its strategic review of TexRAD®, a longstanding part of the Feedback portfolio. The Company hopes to complete the strategic review by the end of the calendar year.

 

-Ends-

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

 

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880

 

Instinctif Partners

Rozi Morris / Phillip Marriage

+44 (0)20 7457 2020

feedbackplc@instinctif.com

 

 

Notes to editors

 

About Feedback plc - www.fbk.com

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

 

Feedback has launched Bleepa®, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa®, see www.bleepa.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDMFBLTMBIBBFL
Date   Source Headline
3rd May 20117:00 amRNSChange of Adviser
25th Feb 20114:04 pmRNSDirector/PDMR Shareholding
22nd Feb 20118:00 amRNSHalf Yearly Report
18th Feb 20114:16 pmRNSDirectorate Change
11th Feb 201111:58 amRNSDirectorate Change
29th Nov 201010:08 amRNSDirector/PDMR Shareholding
29th Oct 20107:00 amRNSFinal Results
29th Apr 20107:00 amRNSDirector/PDMR Shareholding
28th Apr 20107:00 amRNSDirector/PDMR Shareholding
24th Feb 20107:00 amRNSInterim Results
30th Oct 200911:30 amRNSFinal Results
12th Aug 20097:00 amRNSDirectorate Change
17th Feb 20097:00 amRNSHalf Yearly Report
8th Dec 20084:42 pmRNSDirectorate Change
19th Nov 20087:00 amRNSDirector/PDMR Shareholding
23rd Oct 20087:00 amRNSDirector/PDMR Shareholding
15th Oct 20084:59 pmRNSDirector/PDMR Shareholding
9th Oct 20087:00 amRNSFinal Results
2nd Jun 200812:37 pmRNSHolding(s) in Company
30th May 20085:38 pmRNSTotal Voting Rights
21st May 200811:45 amRNSResult of EGM
24th Apr 20087:55 amRNSProperty Purchase
4th Apr 20087:01 amRNSDirectorate Change
26th Mar 200810:06 amRNSDirectorate Change
28th Feb 20088:06 amRNSInterim Results
11th Feb 20089:21 amRNSUpdate on CVA
10th Jan 20087:00 amRNSDirectorate Change
10th Dec 20075:23 pmRNSCapital Reorganisation
10th Dec 20074:00 pmRNSCapital Reorganisation
13th Nov 20077:00 amRNSDirectorate Change
26th Oct 20073:45 pmRNSDirector/PDMR Shareholding
25th Oct 20071:13 pmRNSOffer Talks Terminated
17th Oct 20071:39 pmRNSStatement re Possible Offer
27th Sep 20077:01 amRNSFinal Results
16th Aug 20079:02 amRNSAIM Rule 26 Information
31st Jul 20073:45 pmRNSTotal Voting Rights
25th Jul 20078:26 amRNSDirectorate Change
20th Jul 20074:41 pmRNSDirector/PDMR Shareholding
18th Jul 20074:07 pmRNSHolding(s) in Company
17th Jul 20071:06 pmRNSHolding(s) in Company
9th Jul 20074:30 pmRNSHolding(s) in Company
5th Jul 200710:16 amRNSHolding(s) in Company
2nd Jul 20071:07 pmRNSResult of EGM
5th Jun 20077:02 amRNSIssue of Equity
2nd May 200711:03 amRNSHolding(s) in Company
30th Apr 200712:28 pmRNSTotal Voting Rights
30th Mar 200710:16 amRNSTotal Voting Rights
2nd Mar 20072:31 pmRNSIssue of Equity
7th Feb 20077:01 amRNSUpdate on Property Disposal
21st Dec 200611:29 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.